Global Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Times.

Press releases published on August 11, 2026

Aug. 11, 2026

SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Inuvo Announces Planned Financial Leadership Transitions

Indeterminate GlobeNewswire

Aug. 11, 2026

Snail, Inc. Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Codexis Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 11, 2026

MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program

Indeterminate GlobeNewswire

Aug. 11, 2026

BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire

Aug. 11, 2026

Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing

Indeterminate GlobeNewswire

Aug. 11, 2026

Inuvo Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Top Busbar Machine Manufacturer Advancing Intelligent Electrical Manufacturing Solutions

Indeterminate EIN Presswire

Aug. 11, 2026

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Erasca Reports Second Quarter 2026 Business Updates and Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity

Indeterminate GlobeNewswire

Aug. 11, 2026

Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1

Indeterminate GlobeNewswire

Aug. 11, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 11, 2026

Leonardo DRS Demonstrates Defeat of Group 1-2 Unmanned Aerial System Threats for Fielded SGT STOUT M-SHORAD

Indeterminate GlobeNewswire

Aug. 11, 2026

Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Indeterminate GlobeNewswire